Benzylurea Protects hPDLFs Against LPS ‐Induced Mitochondrial Dysfunction Through MTCH2
Oral Diseases · 2025
DOI: 10.1111/odi.15172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Li Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China. Hauptthemen laut MEDLINE: Mitochondria, Fibroblasts, Periodontal Ligament. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Ningxia Natural Science Foundation project, Ningxia Hui Autonomous Region science and technology benefit people program project.
Abstract (Originalsprache)
Objective
The aim of this study is to explore the mechanism of benzylurea in the inflammatory injury of human periodontal ligament fibroblasts (hPDLFs).
Methods
An inflammation model of hPDLFs was established using LPS. Nuclear transport of nuclear transcription factor‐κB (NF‐κB), secretion of cytokines, and the morphology and distribution of F‐actin were determined. Mitochondrial function was assessed by measuring mitochondrial membrane potential (MMP), mitochondrial permeability transition pore (mPTP), and reactive oxygen species (ROS) levels. The expression of mitochondrial carrier homolog 2 (MTCH2) and Cytochrome b5 type B (CYB5B) was detected.
Results
Benzylurea alleviated the effects of lipopolysaccharide (LPS) on the proliferation and apoptosis of hPDLFs. It reduced the release of inflammatory cytokines and inhibited NF‐κB nuclear translocation. Benzylurea improved mitochondrial function by regulating MMP and preventing excessive mPTP opening. Furthermore, LPS elevated the expression of MTCH2 and reduced the expression of CYB5B in hPDLFs. However, these effects can be inhibited by benzylurea. The altered expression of MTCH2 directly affected CYB5B expression, the release of inflammatory cytokines, and the activation of nuclear translocation of NF‐κB.
Conclusion
CYB5B may act as an effector of MTCH2, with benzylurea enhancing mitochondrial function and protecting hPDLFs from LPS‐induced injury through MTCH2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
- Department of Pharmacy, People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China.
- School of Stomatology, Ningxia Medical University, Yinchuan, Ningxia, China.
- Department of Maxillofacial Surgery, Xiangya School of Stomatology, Central South University, Changsha, Hunan, China.
- Center for Biomedical Engineering, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
ORCID-Profile: Xuancheng Hui, Pengfei Yang
Förderung
- Ningxia Natural Science Foundation project
- Ningxia Hui Autonomous Region science and technology benefit people program project
Zitieren
APA
Liu, L., Bai, J., Wang, J., Fan, J., Yin, D., Chang, H., Hui, X., & Yang, P. (2025). Benzylurea Protects hPDLFs Against LPS ‐Induced Mitochondrial Dysfunction Through MTCH2. Oral Diseases. https://doi.org/10.1111/odi.15172
Vancouver
Liu L, Bai J, Wang J, Fan J, Yin D, Chang H, et al. Benzylurea Protects hPDLFs Against LPS ‐Induced Mitochondrial Dysfunction Through MTCH2. Oral Diseases. 2025. doi:10.1111/odi.15172
BibTeX
@article{Liu2025,
author = {Liu, Li and Bai, Jing and Wang, Jiyun and Fan, Junheng and Yin, Dong and Chang, Hong and Hui, Xuancheng and Yang, Pengfei},
title = {Benzylurea Protects hPDLFs Against LPS ‐Induced Mitochondrial Dysfunction Through MTCH2},
journal = {Oral Diseases},
year = {2025},
doi = {10.1111/odi.15172}
}
EUVIMED